Literature DB >> 14627325

Myocardial cell damage in Duchenne muscular dystrophy.

C Ramaciotti1, S T Iannaccone, W A Scott.   

Abstract

We report two cases of Duchenne muscular dystrophy that presented with laboratory evidence of acute transient myocardial cell damage. The mechanism for development of cardiomyopathy associated with Duchenne muscular dystrophy is not well understood, and this report raises the possibility that the progressive deterioration of cardiac function is punctuated by acute episodes of cell damage.

Entities:  

Mesh：

Year:  2003        PMID： 14627325     DOI： 10.1007/s00246-002-0408-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  10 in total

1.  Cardioprotection for Duchenne's muscular dystrophy.

Authors:  Y Ishikawa; J R Bach; R Minami
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy.

Authors:  A Hammerer-Lercher; P Erlacher; R Bittner; R Korinthenberg; D Skladal; S Sorichter; W Sperl; B Puschendorf; J Mair
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

3.  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  G Nigro; L I Comi; L Politano; R J Bain
Journal:  Int J Cardiol       Date:  1990-03       Impact factor: 4.164

4.  Evidence that human cardiac myocytes divide after myocardial infarction.

Authors:  A P Beltrami; K Urbanek; J Kajstura; S M Yan; N Finato; R Bussani; B Nadal-Ginard; F Silvestri; A Leri; C A Beltrami; P Anversa
Journal:  N Engl J Med       Date:  2001-06-07       Impact factor: 91.245

5.  Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy.

Authors:  M Sander; B Chavoshan; S A Harris; S T Iannaccone; J T Stull; G D Thomas; R G Victor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

7.  Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: a role for coronary dysfunction?

Authors:  T Gnecchi-Ruscone; J Taylor; E Mercuri; G Paternostro; R Pogue; K Bushby; C Sewry; F Muntoni; P G Camici
Journal:  Muscle Nerve       Date:  1999-11       Impact factor: 3.217

Review 8.  The dystrophinopathies: an alternative to the structural hypothesis.

Authors:  C G Carlson
Journal:  Neurobiol Dis       Date:  1998-07       Impact factor: 5.996

9.  Blunted coronary reserve in myotonic dystrophy. An early and gene-related phenomenon.

Authors:  D Annane; P Merlet; H Radvanyi; B Mazoyer; B Eymard; M Fiorelli; C Junien; M Fardeau; Z Ounnoughene; P Gajdos; A Syrota; D Duboc
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

Authors:  R Coral-Vazquez; R D Cohn; S A Moore; J A Hill; R M Weiss; R L Davisson; V Straub; R Barresi; D Bansal; R F Hrstka; R Williamson; K P Campbell
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582
  10 in total
  11 in total

1.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

2.  Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.

Authors:  DeWayne Townsend; Soichiro Yasuda; Sheng Li; Jeffrey S Chamberlain; Joseph M Metzger
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

3.  DMD carrier model with mosaic dystrophin expression in the heart reveals complex vulnerability to myocardial injury.

Authors:  Tatyana A Meyers; Jackie A Heitzman; DeWayne Townsend
Journal:  Hum Mol Genet       Date:  2020-04-15       Impact factor: 6.150

4.  Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice.

Authors:  Brian Bostick; Yongping Yue; Chun Long; Nate Marschalk; Deborah M Fine; Jing Chen; Dongsheng Duan
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

Review 5.  Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

Authors:  Alain van Mil; Geerthe Margriet Balk; Klaus Neef; Jan Willem Buikema; Folkert W Asselbergs; Sean M Wu; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

6.  Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts.

Authors:  Tatyana A Meyers; Jackie A Heitzman; Aimee M Krebsbach; Lauren M Aufdembrink; Robert Hughes; Alessandro Bartolomucci; DeWayne Townsend
Journal:  J Mol Cell Cardiol       Date:  2019-01-19       Impact factor: 5.000

7.  Murine cardiosphere-derived cells are impaired by age but not by cardiac dystrophic dysfunction.

Authors:  Lien-Cheng Hsiao; Filippo Perbellini; Renata S M Gomes; Jun Jie Tan; Silvia Vieira; Giuseppe Faggian; Kieran Clarke; Carolyn A Carr
Journal:  Stem Cells Dev       Date:  2014-01-31       Impact factor: 3.272

8.  Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.

Authors:  Venus Ameen; Lesley G Robson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

9.  Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.

Authors:  Sophie Mavrogeni; Aikaterini Giannakopoulou; Antigoni Papavasiliou; George Markousis-Mavrogenis; Roser Pons; Evangelos Karanasios; Michel Noutsias; Genovefa Kolovou; George Papadopoulos
Journal:  BMC Cardiovasc Disord       Date:  2017-07-24       Impact factor: 2.298

Review 10.  Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.